Antimicrobial-resistant bacteria including *Escherichia coli* are common contaminants of the industrial broiler chicken environment ([@b14-ehp0115-001738]; [@b17-ehp0115-001738]). Studies conducted in Europe indicate that poultry growers and poultry-house workers are at risk of exposure to these and other pathogens ([@b26-ehp0115-001738]; [@b34-ehp0115-001738]). Similar studies must be conducted in the United States in order to measure occupational exposure to antimicrobial-resistant *E. coli* in the U.S. broiler chicken industry.

Antimicrobial use has been integral to the industrialization of food-animal production. Over the past half century, food-animal production has changed from a largely entrepreneurial system run by independent farmers to an industrial mode of production in which a small number of companies control all aspects of production, from breeding and feed formulation to slaughter and distribution of consumer products. This shift in both the organization and methods of production has allowed for the reliable, high-throughput production of food animals on a scale not seen in human history. In the United States alone, \> 9 billion food animals are produced annually ([@b31-ehp0115-001738]). Antimicrobials have been used in food-animal production since the early days of their discovery ([@b36-ehp0115-001738]). Although exact figures are unavailable, it is currently estimated that at least half of all of the antimicrobials consumed in the United States are used in food-animal production ([@b29-ehp0115-001738]). Antimicrobials are used for multiple purposes including outbreak control, prophylaxis, and growth promotion. The antimicrobials approved for use in the U.S. food-animal industry include many drugs of critical importance to human medicine. Sixteen antimicrobial agents from 10 antimicrobial classes are currently approved for use in U.S. poultry production ([Appendix 1](#app1-ehp0115-001738){ref-type="app"}). Among these, gentamicin (GEN) is reported to be the most commonly used antimicrobial ([@b22-ehp0115-001738]).

The use of antimicrobials in industrial food-animal production selects for antimicrobial-resistant bacterial populations. Antimicrobial-resistant bacteria have been detected in animal wastes ([@b15-ehp0115-001738]), animal bedding ([@b16-ehp0115-001738]), air both inside ([@b5-ehp0115-001738]) and downwind ([@b10-ehp0115-001738]) of animal feeding operations, in groundwater near animal feeding operations ([@b1-ehp0115-001738]), and in consumer meat and poultry products ([@b8-ehp0115-001738]). There is substantial evidence that antimicrobial use in food-animal production contributes to the burden of antimicrobial-resistant diseases in human populations through foodborne routes of exposure. Examples include infections with fluoro-quinolone-resistant *Campylobacter* ([@b12-ehp0115-001738])*,* vancomycin-resistant *Enterococci* (VRE) ([@b4-ehp0115-001738]), multidrug-resistant *Salmonella* ([@b24-ehp0115-001738]), and multidrug-resistant *E. coli* ([@b28-ehp0115-001738]). Additional pathways likely exist through exposure to contaminated environmental media in and around animal production facilities as well as contact with animals in the occupational setting.

Some of the seminal reports connecting antimicrobial use in food-animal production with antimicrobial-resistant human infections and colonization involved studies of farmers and their families ([@b19-ehp0115-001738]; [@b20-ehp0115-001738]). These early reports have been confirmed by more recent case studies ([@b7-ehp0115-001738]; [@b27-ehp0115-001738]). Occupational epidemiology studies of European broiler farmers and turkey farmers, as well as broiler and turkey slaughterhouse workers, indicated that these populations were at increased risk of colonization with antimicrobial-resistant *E. coli* and *Enterococcus* because of their occupational exposure to these animals ([@b30-ehp0115-001738]; [@b33-ehp0115-001738], [@b34-ehp0115-001738], [@b35-ehp0115-001738]). To date, no studies have been published assessing the occupational exposures to antimicrobial-resistant enteric bacteria incurred by workers in the U.S. broiler industry.

The U.S. broiler industry is estimated to employ \> 200,000 people ([@b32-ehp0115-001738]), and the industrialization of production has resulted in the division of labor into specific tasks. Most broiler houses are owned and operated by independent farmers called "growers." Growers typically raise chickens under contract with production companies or integrators. At the end of the grow-out period, chickens are captured by people called "catchers," placed into cages, and transported to the slaughtering facilities. Once delivered to the slaughterhouse, the broilers are removed from the cages and shackled to semiautomated slaughter lines by people called "live hangers." Thus, growing, catching, and hanging are the three tasks with the most intensive live-animal exposures. For example, a catcher will capture and cage thousands of chickens in a single workday ([@b11-ehp0115-001738]). Defining risks for these highly exposed populations may have relevance to understanding the dissemination of antimicrobial-resistant bacteria more generally within communities.

In the present study, we compared the risk of antimicrobial-resistant *E. coli* colonization among poultry workers (i.e., growers, catchers, and live hangers) and rural community referents. We cultured stool samples for *E. coli* and determined the susceptibility of isolates to six different antimicrobials. We estimated the relative risk for colonization with antimicrobial-resistant *E. coli* among poultry workers compared to referents.

Materials and Methods
=====================

The present study was designed as a convenience sample of poultry workers and community residents in the eastern shore region of Maryland and Virginia. The study complied with all U.S. regulations regarding research on human subjects and was approved by the Johns Hopkins Medical Institutions Committee on Human Subjects Research. All human subjects provided written informed consent prior to participating in the study.

Study site and enrollment
-------------------------

Subjects were recruited and enrolled 29 April--1 May 2005 and 4--5 December 2005 at several sites in southern Maryland and Virginia on the Delmarva Peninsula. This region is among the top five broiler chicken regions in the United States, producing \> 600 million chickens annually. Subjects were recruited and enrolled into the study using a convenience-sampling approach, leveraging public notices (fliers and newspaper advertisements), personal outreach through a local nongovernmental organization (Delmarva Poultry Justice Alliance), and door-to-door inquiries in neighborhoods known to be populated by poultry workers. The study excluded anyone \< 18 years of age, those employed in the medical industry, those working in a poultry processing plant, and those who had traveled outside the United States in the past 3 months. A modest incentive (\$25 gift certificate) was offered to those willing to complete a questionnaire and provide stool samples for analysis.

Questionnaire
-------------

After meeting the minimum inclusion criteria for the overall health study, subjects were administered a face-to-face questionnaire consisting of three parts. Part 1 covered demographic information including sex, race, and level of education; employment status within the past 6 months; health insurance status; and primary source of health care (i.e., doctor's office, hospital, workplace, or other). Part 2 included nonoccupational risks for exposure to antimicrobial-resistant *E. coli* from animal sources such as well water, ground red meat, and poultry consumption, and the presence of pets in the household. Part 3 was directed to those reporting recent or current employment in the broiler chicken industry, and requested information on job title (catcher, grower, or live hanger), duration of employment, average frequency of exposure over the course of a week, and days worked in the week immediately before study participation. Subjects were also asked about availability and use of personal protective equipment. Finally, subjects were asked whether clothing worn at work was laundered at home. All data were collected under complete confidentiality; after enrollment, each subject was identified solely by an alphanumeric code.

Stool collection and culture
----------------------------

Participants were provided a stool sample collection kit (Fisher Scientific, Pittsburgh, PA) and were asked to produce and collect a sample on site or to take the kit home and return a sample within 4 hr of collection. Stool samples were transferred to Enteric Plus transport media (Meridian Bioscience, Cincinnati, OH) ([@b38-ehp0115-001738]) and kept at 4°C until they were cultured in the laboratory within 72 hr of arrival. *Enterobacteriaceae* was cultured from the transport media on standard Violet Red Bile Glucose Agar (Oxoid, Hampshire, UK) and on Violet Red Bile Glucose Agar supplemented with one each of the following antimicrobials: ampicillin (AMP), 16 μg/mL; ciprofloxacin (CIP), 2 μg/mL; ceftriaxone (CEF), 32 μg/mL; GEN, 8 μg/mL; and tetra-cycline (TET), 8 μg/mL (i.e., each sample was cultured on six different media formulations). Isolates were purified twice on the same medium on which they were isolated. All isolates were stored at −80°C until they were tested for antimicrobial susceptibility as described below. Selective antimicrobials were used to increase the sensitivity of the assay for detecting resistant *E. coli* strains among a mix of resistant and susceptible strains within the stool sample.

Susceptibility testing
----------------------

Minimal inhibitory concentrations were determined by the agar dilution method using *E. coli* ATCC 25922 and *E. coli* ATCC 35218 (both from American Type Culture Collection, Manassas, VA) as reference strains as recommended by guidelines of the [@b6-ehp0115-001738]. The dilution ranges (resistance breakpoints) were as follows: AMP, 0.25--32 (32); CIP, 0.004--8 (4); CEF, 0.06--64 (64); GEN, 0.25--16 (16); NIT, 2--256 (128); and TET, 1--16 (16).

Species identification
----------------------

Isolates were identified to the species level using the Microbact 12A (12E) Gram-Negative Identification System---Strip Format (Oxoid). Following the protocol provided by the manufacturer, isolates were cultured for 24 hr on Mueller-Hinton blood agar, confirmed oxidase-negative, suspended in a saline solution, and incubated for 24 hr in a test strip containing 12 distinct substrates commonly used for *Enterobacteriaceae* species identification. Strips were scored based on color change, and results were correlated with genus and species using the Microbact 2000 Identification Package, V2.03 for Windows (Oxoid). Only those isolates positively identified as *E. coli* were used for outcome analyses.

Sample scoring
--------------

Stool samples were plated on six different agars as described above; therefore, up to six isolates were cultured from each participant (i.e., one isolate per agar formulation). If ≥1 of the *E. coli* isolates from a participant's stool sample was resistant to an antimicrobial, the sample was scored as resistant. If any single isolate from a participant's stool culture was resistant to ≥2 antimicrobials, the sample was scored as multidrug resistant. In total, eight different antimicrobial resistance outcomes were measured: AMP resistance, CIP resistance, CEF resistance, GEN resistance, NIT resistance, TET resistance, antimicrobial resistance (any of the six), and multidrug resistance (≥2).

Data entry
----------

Questionnaire data were entered into a database using EpiData 3.1 ([@b18-ehp0115-001738]) by two different researchers. Referencing the original questionnaires allowed for inconsistencies between the independent entries to be rectified.

Statistical analyses
--------------------

We used odds ratios, Fisher's exact tests, and chi-square analyses to assess the associations between exposure (poultry worker vs. community reference) and the eight outcomes. Bivariate logistic regression was used to measure these associations while adjusting for self-reported antibiotic use during the month before sample collection. All statistical analyses were performed using Stata 8.0 (StataCorp, College Station, TX).

Results
=======

Seventy-one people were enrolled into our study, but 49 subjects were included in the analyses presented here. Nine people were excluded because they shared a residence with a poultry worker, and 13 were excluded because *E. coli* was not recovered from their stool samples. There was not a significant difference in the proportion of poultry workers and community referents dropped for lack of an *E. coli* culture; therefore, their exclusion did not affect the internal validity of the study.

Poultry workers (*n* = 16) and community referents (*n* = 33) were similar with respect to most of the general characteristics assessed in the study ([Table 1](#t1-ehp0115-001738){ref-type="table"}). There were fewer poultry workers who reported completing high school than community referents, but we did not consider this to be a potential confounder for the analyses presented here.

Most nonoccupational risk factors for colonization with antimicrobial-resistant *E. coli* were similar between the two exposure groups. Poultry workers and community referents were similar with respect to self-reported exposures to potential sources of animal-associated antimicrobial-resistant *E. coli*, including ground red meat, poultry, and well-water consumption, as well as keeping pets ([Table 2](#t2-ehp0115-001738){ref-type="table"}). The two groups were also similar in the proportion of participants who sought health care in the month before the study. However, poultry workers were more than two times as likely as referents to report antibiotic use during this same period ([Table 2](#t2-ehp0115-001738){ref-type="table"}). Self-reported antibiotic use was associated with increased odds for all eight outcomes of interest ([Table 3](#t3-ehp0115-001738){ref-type="table"}) and therefore was included in multivariate logistic regression models.

Poultry workers had 32 times the odds of being colonized with GEN-resistant *E. coli* compared with community referents ([Table 4](#t4-ehp0115-001738){ref-type="table"}). AMP-resistant and TET-resistant *E. coli* carriage was common among both groups and not significantly different between them ([Table 4](#t4-ehp0115-001738){ref-type="table"}). In contrast, CIP-, CEF-, and NIT-resistant *E. coli* were uncommon in both groups--- too rare to calculate relative risk estimates. Nine different multidrug-resistance patterns were identified among the *E. coli* strains collected ([Appendix 2](#app2-ehp0115-001738){ref-type="app"}). Carriage of multidrug-resistant *E. coli* was significantly more common in poultry workers and was largely attributable to the disproportionate prevalence of GEN resistance ([Table 4](#t4-ehp0115-001738){ref-type="table"}). Adjusting for self-reported antibiotic use in multivariate logistic analyses did not change the overall trends and had little effect on the individual associations ([Table 4](#t4-ehp0115-001738){ref-type="table"}).

Discussion
==========

This is the first U.S.-based study to assess the risk for colonization with antimicrobial-resistant *E. coli* from occupational exposure to live chickens in the broiler chicken industry. The results presented here confirm similar studies in Europe showing that poultry farmers and slaughterhouse workers were at excess risk for colonization with antimicrobial-resistant *E. coli* ([@b34-ehp0115-001738]).

In the present study, 50% of the poultry workers were colonized with GEN-resistant *E. coli*. This was in stark contrast to the proportion of community referents colonized with GEN-resistant *E. coli* (3%) and to the rates reported among hospital isolates (6.3%) ([@b9-ehp0115-001738]). Aminoglycosides are not absorbed through the gastrointestinal tract; therefore, human use is limited to intravenous, intramuscular, subcutaneous, and topical administration. The inability to administer GEN orally limits outpatient use; thus, there is probably minimal selection of GEN-resistant *E. coli* in the community. In contrast, GEN has been reported to be the most commonly used antimicrobial in broiler production, where it is administered prophylactically to day-old chicks to prevent bacterial infections ([@b22-ehp0115-001738]). GEN resistance is common among poultry-associated enteric bacteria. A recent survey revealed that 69% of avian pathogenic *E. coli* isolates were resistant to GEN ([@b39-ehp0115-001738]). The disproportionately high prevalence of GEN-resistant *E. coli* among the poultry workers in the present study is consistent with the hypothesis that poultry workers are at increased risk of becoming colonized with antimicrobial-resistant *E. coli* resulting from occupational exposures to these strains in the broiler chicken environment.

We acknowledge the limitations of the present study, particularly the small sample size. The study design was a community-based convenience sample necessitated by the fact that poultry workers in contact with live poultry are unorganized and often contracted by integrators. Thus, there was no reliable way to recruit subjects through labor organizations or employers. The sample size was further limited by our inability to culture *E. coli* from the stools of 13 participants. Culture recovery might have been improved by using a type of medium more selective for *E. coli*. Stool sample cultivability may also have been reduced because of variable delays between the time participants collected their stool samples and the time they delivered them to researchers (participants were requested to do so within 4 hr). There was not a significant difference in the proportion of poultry workers and community referents dropped from the analysis due to negative cultures; therefore, the internal validity of the study was not affected by this limitation.

We did not ascertain health outcomes that may have been related to antimicrobial-resistant *E. coli* colonization, but the increased colonization rates among poultry workers may be associated with increased health risks in this population. Poultry-associated multidrug-resistant strains of *E. coli* have been shown to cause urinary tract infections and sepsis in the community ([@b23-ehp0115-001738]; [@b28-ehp0115-001738]). Furthermore, antibiotic-resistant *E. coli* can serve as a reservoir of mobile resistance determinants that can be transferred to pathogenic bacterial species ([@b3-ehp0115-001738]). Thus, harboring *E. coli* with these determinants may increase one's risk for developing an antimicrobial-resistant infection.

Colonization with antimicrobial-resistant *E. coli* may also pose a health risk to poultry workers' families and community contacts. Community-based studies indicate that strains of antimicrobial-resistant *E. coli* are often shared among family members and between domestic partners ([@b13-ehp0115-001738]; [@b21-ehp0115-001738]). In addition to the fecal--oral route, poultry workers' household contacts may be exposed to antimicrobial-resistant *E. coli* from contaminated work clothes (88% of poultry workers in the present study reported laundering their work clothes at home; data not shown).

To determine whether colonization by *E. coli* is transient or long-term among poultry workers, prospective studies complemented by detailed genetic analysis will be required. Likewise, such analyses can reveal whether mobile resistance elements are transferring resistance to native microbial flora in poultry workers. Additional studies will also be necessary to evaluate the potential for negative health outcomes associated with colonization by antimicrobial-resistant *E. coli* and to determine risks of exposure for household contacts of poultry workers.

A number of U.S. poultry producers have announced that they have substantially reduced their antimicrobial consumption by discontinuing the use of antimicrobial growth promoters (antimicrobials added to feed to promote growth) ([@b37-ehp0115-001738]). GEN is not approved for growth promotion in the United States; therefore, consumption rates will be unaffected by decreases in antimicrobial growth promoters. The decision by Tyson Foods (Springdale, AR), one of the nation's largest poultry producers, to stop using antibiotics altogether for chickens marketed fresh in the United States could result in a substantial reduction in GEN use; however, this change will be implemented at less than half of their U.S. production facilities ([@b2-ehp0115-001738]). Furthermore, it is unclear whether this new antimicrobial use policy will be implemented at Tyson's foreign production plants.

Conclusion
==========

Occupational exposure to live animals in the broiler chicken industry may be an important route of entry for antimicrobial-resistant bacteria into the community. The present study revealed a disproportionately high rate of colonization with GEN-resistant *E. coli* among U.S. poultry workers. Although there have been reports of decreased antimicrobial consumption by some U.S. poultry producers, antimicrobial use is still common in broiler chicken production in the United States and around the world. The continued use of GEN for food-animal production threatens the clinical utility of this and other aminoglycosides for human medicine.
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  Antimicrobial class   Agent
  --------------------- -----------------------------------------------------------------
  Aminocoumarin         Novobiocin
  Aminocyclitols        Spectinomycin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
  Aminoglycosides       Streptomycin
                        Neomycin
                        Gentamicin
  β-Lactams             Penicillin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
  Decapeptides          Bacitracin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
  Lincosamides          Lincomycin
  Macrolides            Erythromycin
                        Tylosin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
                        Oleandomycin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
  Organoarsenicals      Roxarsone
  Phosphoglycolipids    Bambermycin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
  Streptogramins        Virginiamycin[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
  Tetracyclines         Chlortetracycline[a](#tfn6-ehp0115-001738){ref-type="table-fn"}
                        Oxytetracycline
                        Tetracycline

Labeled as growth promoter

  AMP^R^   CIP^R^   CEF^R^   GEN^R^   NIT^R^   TET^R^   No. of strains
  -------- -------- -------- -------- -------- -------- ----------------
  x                                            x        1
  x                 x                                   1
  x        x                                            1
  x                                            x        4
                             x                 x        2
  x                                            x        3
                             x                 x        4
  x        x                                   x        1
  x                          x        x                 1

R, resistant to that specific antimicrobial.

###### 

Participant characteristics \[percent (no.)\] for community referents (CR; *n* = 33) and poultry workers (PW; *n* = 16).

  Characteristic                                                   CR            PW
  ---------------------------------------------------------------- ------------- ------------
  Age \[years (mean ± SD)\]                                        42.5 ± 13.1   46.4 ± 8.3
  Sex                                                                            
   Male                                                            69.7 (23)     88.9 (16)
   Female                                                          30.3 (10)     11.1 (2)
  Race                                                                           
   White                                                           12.1 (4)      16.7 (3)
   Black                                                           87.9 (29)     77.8 (14)
   Other                                                           0 (0)         5.5 (1)
  Education                                                                      
   \< High school                                                  39.4 (13)     61.1 (11)
   High school[\*](#tfn2-ehp0115-001738){ref-type="table-fn"}      45.5 (15)     16.7 (3)
   \> High school                                                  15.1 (5)      22.2 (4)
  Health insurance[a](#tfn1-ehp0115-001738){ref-type="table-fn"}                 
   Yes                                                             60.6 (20)     72.2 (13)
   No                                                              39.4 (13)     27.8 (5)

Health insurance data were missing for one CR.

Significantly different between exposure groups (*p* \< 0.05).

###### 

Nonoccupational risk factors \[percent (no.)\] for antimicrobial-resistant *E. coli* carriage exposure in community referents (CR; *n* = 33) and poultry workers (PW; *n* = 16).

  Risk factor                     CR           PW
  ------------------------------- ------------ ------------
  Antibiotic use previous month                
   Yes                            18.2 (6)     33.3 (6)
   No                             81.8 (27)    66.7 (12)
  Health care in previous month                
   Yes                            15.2 (5)     12.5 (2)
   No                             84.8 (28)    87.5 (14)
  Consume ground red meat                      
   Yes                            93.9 (31)    100.0 (18)
   No                             6.1 (2)      0 (0)
  Consume poultry                              
   Yes                            100.0 (33)   100.0 (18)
   No                             0 (0)        0 (0)
  Own pets                                     
   Yes                            33.3 (11)    12.5 (2)
   No                             66.7 (22)    87.5 (14)
  Drinking water source                        
   In/out well                    33.3 (11)    38.9 (7)
   Public water                   36.4 (12)    44.4 (8)
   Bottled water                  27.3 (9)     11.1 (2)
   Unknown                        3.0 (1)      5.5 (1)

###### 

Odds of antimicrobial-resistant *E. coli* among participants reporting any antibiotic use during the month before the study.

           Antimicrobial-resistant cases   Antimicrobial user/nonuser                       
  -------- ------------------------------- ---------------------------- ------------------- -------
  AMP^R^   83.3 (10)                       54.1 (20)                    4.25 (0.73--44.0)   0.071
  CIP^R^   16.7 (2)                        2.7 (1)                      7.20 (0.33--436)    0.080
  CEF^R^   0.0 (0)                         2.7 (1)                      ---                 0.565
  GEN^R^   25.0 (3)                        16.2 (6)                     1.72 (0.23--10.1)   0.495
  NIT^R^   0.0 (0)                         2.7 (1)                      ---                 0.565
  TET^R^   50.0 (6)                        37.8 (14)                    1.64 (0.36--7.47)   0.456
  R        91.7 (11)                       67.6 (25)                    5.28 (0.61--246)    0.100
  MDR      58.3 (7)                        29.7 (11)                    3.31 (0.71--16.0)   0.074

Abbreviations: CI, confidence interval; MDR, multidrug resistant; OR, odds ratio; R, resistant to ≥1 antimicrobials (superscript indicates resistance to a specific antimicrobial).

###### 

Odds of antimicrobial-resistant *E. coli* among poultry workers and community referents.

           Antimicrobial- resistant cases   PW/CR (unadjusted)   PW/CR (adjusted)[a](#tfn5-ehp0115-001738){ref-type="table-fn"}                                  
  -------- -------------------------------- -------------------- ---------------------------------------------------------------- ---------- ------------------- -------
  AMP^R^   62.5 (10)                        60.6 (20)            1.08 (0.27--4.56)                                                0.899      0.83 (0.22--3.10)   0.786
  CIP^R^   6.25 (1)                         6.06 (2)             1.03 (0.02--21.3)                                                0.979      0.63 (0.05--8.74)   0.730
  CEF^R^   6.25 (1)                         0.00 (0)             ---                                                              0.147      ---                 ---
  GEN^R^   50.0 (8)                         3.03 (1)             32.0 (3.21--1,462)                                               \< 0.001   33.1 (3.47--316)    0.002
  NIT^R^   6.25 (1)                         0.00 (0)             ---                                                              0.147      ---                 ---
  TET^R^   56.3 (9)                         33.3 (11)            2.57 (0.64--10.5)                                                0.126      2.43 (0.70--8.48)   0.163
  R        81.3 (13)                        69.7 (23)            1.88 (0.38--12.4)                                                0.390      1.52 (0.34--6.90)   0.584
  MDR      62.5 (10)                        24.2 (8)             5.21 (1.21--23.1)                                                0.009      4.61 (1.23--17.2)   0.023

Abbreviations: CI, confidence interval; CR, community referent; MDR, multidrug resistant; PW, poultry worker; R, resistant to ≥ 1 antimicrobials (superscript indicates resistance to a specific antimicrobial).

Based on logistic regression model adjusting for self-reported use of any antibiotics during the month before sample collection.
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